Jeddah Valley Boosts Pharma Investment

Wadi Jeddah Company, the investment arm of King Abdulaziz University, is seeking to expand its investments in the pharmaceutical industry and knowledge-based technologies through "Teryaq" Pharmaceuticals. Over the past two years, the company has launched 13 pharmaceutical products in the Saudi market, with plans to broaden its range to include products related to respiratory and gastrointestinal diseases, as well as medical supplements. Additionally, the company intends to launch a bold investment fund valued at $10 million at the beginning of 2027, aimed at supporting startups within the Wadi Jeddah ecosystem and beyond. The focus will be on areas such as smart cities, future transportation, biotech, food and pharmaceutical manufacturing. The goal is to overcome funding challenges, foster company growth, and develop innovative products.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل